Skip to content

Adaptive Biotechnologies ADPT Other Non-Current Assets

Other Non-Current Assets at other companies

Monte Rosa Therapeutics, Inc. logo
Monte Rosa Therapeutics, Inc.GLUE
$832K+89.1%
GeneDx Holdings logo
GeneDx HoldingsWGS
$4.28M+0.7%
Veracyte logo
VeracyteVCYT
$1.03M-85.4%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$7.41M+31.7%
Guardant Health logo
Guardant HealthGH
Natera, Inc. logo
Natera, Inc.NTRA

Other financials

Income statement

See full
Revenue$70.9M+35.1%
Gross profit$52.2M+47.1%
Operating income-$19.2M+35.1%
Net income-$20.0M+32.9%
EPS (diluted)-$0.13+35.0%

Balance sheet

See full
Cash & equivalents$77.6M+53.2%
Total debt$208.2M-5.6%
Total equity$216.3M+13.6%
Total assets$505.9M-1.0%

Cash flow

See full
Operating cash flow-$9.5M+66.5%
CapEx$796.0K-36.8%
Free cash flow-$10.3M+65.3%

Valuation

See full
Market cap$2.76B+93.6%
Enterprise value$2.89B+78.0%
P/S9.3×+1.8×

Profitability

See full
Gross margin75.3%+12.7pp
Operating margin-15.8%-7.0pp
Net margin-16.8%-7.3pp
FCF margin-10.5%-4.6pp

Returns & leverage

See full
Return on equity-24.4%-9.2pp
Debt / equity-0.2×
Current ratio3.4×+0.4×

Where this comes from

Reported directly by Adaptive Biotechnologies in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Adaptive Biotechnologies's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Adaptive Biotechnologies's other non-current assets?
Adaptive Biotechnologies (ADPT) reported other non-current assets of $1.24M in Q1 2026.
How has Adaptive Biotechnologies's other non-current assets changed year-over-year?
Adaptive Biotechnologies's other non-current assets decreased by 34.4% year-over-year, from $1.89M to $1.24M.
What is the long-term trend for Adaptive Biotechnologies's other non-current assets?
Over 5 years (2020 to 2025), Adaptive Biotechnologies's other non-current assets has grown at a 15.1% compound annual growth rate (CAGR), from $598K to $1.21M.
What does other non-current assets mean?
This category captures long-term assets that do not fit into standard classifications like property, plant, equipment, or intangible assets. It may include long-term deposits, deferred tax assets, or other miscellaneous non-current investments. It represents the residual value of long-term resources held by the company.